[Federal Register Volume 78, Number 147 (Wednesday, July 31, 2013)] [Notices] [Page 46372] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2013-18337] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Ampac Fine Chemicals, LLC. Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 6, 2013, AMPAC Fine Chemicals, LLC., Highway 50 and Hazel Avenue, Building 05001, Rancho Cordova, California 95670, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methylphenidate (1724)..................... II Thebaine (9333)............................ II Poppy Straw Concentrate (9670)............. II Tapentadol (9780).......................... II ------------------------------------------------------------------------ The company is a contract manufacturer. In reference to Poppy Straw Concentrate the company will manufacture Thebaine intermediates to sale to its customers for further manufacture. No other activity for this drug code is authorized for this registration. Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than September 30, 2013. Dated: July 23, 2013. Joseph T. Rannazzisi Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013-18337 Filed 7-30-13; 8:45 am] BILLING CODE 4410-09-P